Search

Author/Creator Lock, Richard B.

1. Efficacy of CPX‐351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program. Issue 1 (9th September 2014)

Authors:
Carol, Hernan; Fan, Mannie M. Y.; Harasym, Troy O.; Boehm, Ingrid; Mayer, Lawrence D.; Houghton, Peter; Smith, Malcolm A.; Lock, Richard B.
Journal:
Pediatric blood & cancer
Issue:
Volume 62:Issue 1(2015:Jan.)
Page Start:
65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Initial testing (stage 1) of BAL101553, a novel tubulin binding agent, by the pediatric preclinical testing program. Issue 6 (18th November 2014)

Authors:
Kolb, E. Anders; Gorlick, Richard; Keir, Stephen T.; Maris, John M.; Kang, Min H.; Reynolds, C. Patrick; Lock, Richard B.; Carol, Hernan; Wu, Jianrong; Kurmasheva, Raushan T.; Houghton, Peter J.; Smith, Malcolm A.
Journal:
Pediatric blood & cancer
Issue:
Volume 62:Issue 6(2015:Jun.)
Page Start:
1106
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the pediatric preclinical testing program1. Issue 7 (9th January 2013)

Authors:
Lock, Richard B.; Carol, Hernan; Maris, John M.; Kang, Min H.; Reynolds, C. Patrick; Kolb, E. Anders; Gorlick, Richard; Keir, Stephen T.; Billups, Catherine A.; Kurmasheva, Raushan T.; Houghton, Peter J.; Smith, Malcolm A.
Journal:
Pediatric blood & cancer
Issue:
Volume 60:Issue 7(2013:Jul.)
Page Start:
E42
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Initial testing (stage 1) of the notch inhibitor PF‐03084014, by the pediatric preclinical testing program. Issue 8 (24th March 2014)

Authors:
Carol, Hernan; Maris, John M.; Kang, Min H.; Reynolds, C. Patrick; Kolb, E. Anders; Gorlick, Richard; Keir, Stephen T.; Wu, Jianrong; Kurmasheva, Raushan T.; Houghton, Peter J.; Smith, Malcolm A.; Lock, Richard B.
Journal:
Pediatric blood & cancer
Issue:
Volume 61:Issue 8(2014:Aug.)
Page Start:
1493
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program. Issue 3 (24th November 2015)

Authors:
Gorlick, Richard; Kolb, E. Anders; Keir, Stephen T.; Maris, John M.; Lock, Richard B.; Carol, Hernan; Reynolds, C. Patrick; Kang, Min H.; Billups, Catherine A.; Collins, Jerry; Kurmashev, Dias; Kurmasheva, Raushan T.; Houghton, Peter J.; Smith, Malcolm A.
Journal:
Pediatric blood & cancer
Issue:
Volume 63:Issue 3(2016)
Page Start:
443
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Initial testing of the MDM2 inhibitor RG7112 by the pediatric preclinical testing program1. Issue 4 (2nd July 2012)

Authors:
Carol, Hernan; Reynolds, C. Patrick; Kang, Min H.; Keir, Stephen T.; Maris, John M.; Gorlick, Richard; Kolb, E. Anders; Billups, Catherine A.; Geier, Brian; Kurmasheva, Raushan T.; Houghton, Peter J.; Smith, Malcolm A.; Lock, Richard B.
Journal:
Pediatric blood & cancer
Issue:
Volume 60:Issue 4(2013:Apr.)
Page Start:
633
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Initial testing of VS‐4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program. Issue 4 (27th October 2016)

Authors:
Kurmasheva, Raushan T.; Gorlick, Richard; Kolb, E. Anders; Keir, Stephen T.; Maris, John M.; Lock, Richard B.; Carol, Hernan; Kang, Min; Reynolds, C. Patrick; Wu, Jianrong; Houghton, Peter J.; Smith, Malcolm A.
Journal:
Pediatric blood & cancer
Issue:
Volume 64:Issue 4(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Optimization of a clofarabine‐based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia. Issue 4 (25th December 2019)

Authors:
Xie, Jinhan; Span, Miriam; van Maarseveen, Erik; Langenhorst, Jurgen; Boddy, Alan V.; Sia, Keith C.S.; Sutton, Rosemary; Venn, Nicola; Punt, Arjen M.; Tyrrell, Vanessa; Haber, Michelle; Trahair, Toby; Lau, Loretta; Marshall, Glenn M.; Lock, Richard B.
Journal:
Pediatric blood & cancer
Issue:
Volume 67:Issue 4(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Potent antileukemic activity of curaxin CBL0137 against MLL‐rearranged leukemia. Issue 7 (8th August 2019)

Authors:
Somers, Klaartje; Kosciolek, Angelika; Bongers, Angelika; El‐Ayoubi, Ali; Karsa, Mawar; Mayoh, Chelsea; Wadham, Carol; Middlemiss, Shiloh; Neznanov, Nickolay; Kees, Ursula R.; Lock, Richard B.; Gudkov, Andrei; Sutton, Rosemary; Gurova, Katerina; Haber, Michelle; Norris, Murray D.; Henderson, Mich...
Journal:
International journal of cancer
Issue:
Volume 146:Issue 7(2020)
Page Start:
1902
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗